Clinical Connection Home
  Welcome To
Clinical Connection
 
Be notified of new studies!
Find Clinical Trials!
Message Board
Share This Page
Bruxism Clinical Trials, Diagnosis, and Treatment
Thank you for your interest in clinical trials for Bruxism.

Please click "Search" to find Bruxism clinical trials and medical research studies or read below for information on Bruxism diagnosis and treatment.

If you receive too many study listings you may enter your zip code to find the locations closest to you.


Any Of These Words:
OR
All Of These Words
OR
This Exact Phrase:
AND
Zip Code:
Distance:
Your Search Returned No Results.
Search results will appear below.
Browse All Available Clinical Trials

Join Now to be Notified of New Clinical Trials

View Information and Clinical Trials for Other Conditions


Bruxism

Bruxism (from the Greek βρυγμός (brugmós), gnashing of teeth) is grinding of the teeth, typically accompanied by clenching of the jaw. It is an oral parafunctional activity that occurs to some extent in most humans. Bruxism is caused by the activation of reflex chewing activity; it is not a learned habit. Chewing is a complex neuromuscular activity that is controlled by reflex nerve pathways, with higher control by the brain. During sleep, the reflex part is active while the higher control is inactive, resulting in bruxism. In most people, bruxism is mild enough not to be a health problem; however, some people suffer from significant bruxism that can become symptomatic.

Bruxism often occurs during sleep and can even occur during short naps. Bruxism is one of the most common sleep disorders: 30 to 40 million Americans grind their teeth during sleep.

Current Research

For current research articles click - here

Associated Factors

The etiology of bruxism is unknown; the following factors may be associated with the condition.
  • Disturbed sleep pattern/Other sleep disorders (Obstructive sleep apnea, snoring, moderate daytime sleepiness)
  • Malocclusion, in which the upper and lower teeth fit together in a dysfunctional way, typically through lateral asymmetry and dysocclusion of the front teeth through premature contact of back teeth.
  • Relatively high levels of consumption of caffeinated drinks and foods, such as coffee, colas, and chocolate
  • High levels of alcohol consumption
  • Smoking
  • Consumption of MDMA and Cocaine
  • High levels of anxiety and/or stress
  • Digestive problems
  • Hypersensitivity of the dopamine receptors in the brain
  • Consumption of drugs and medications of the amphetamine-based family, such as MDMA
  • Excessive use of (i.e., frequent redosing and dependancy on) GHB and similar GABA-inducing analogues such as Phenibut
  • Disorders such as Huntington's and Parkinson's disease


Signs, Symptoms and Sequelae

Bruxism can result in abnormal wear patterns of the occlusal surface, abfractions and fractures in the teeth. This type of damage is categorised as a sign of occlusal trauma.

Over time, dental damage will usually occur. Bruxism is the leading cause of occlusal trauma and a significant cause of tooth loss and gum recession.

In a typical case, the canines and incisors of the oppsoting arches are moved against each other laterally, i.e. with a side-to-side action by the lateral pterygoid muscles that lie medial to the temporomandibular joints bilaterally. This movement abrades tooth structure, and can lead to the wearing down of the incisal edges of the teeth. People with bruxism may also grind their posterior teeth, which will wear down the cusps of the occlusal surface. Bruxing can be loud enough to wake a sleeping partner. Some individuals will clench the jaw without significant lateral movements.

Eventually, bruxing shortens and blunts the teeth being ground, and may lead to myofacial muscle pain and headaches. In severe, chronic cases, it can lead to arthritis of the temporomandibular joints.

Most bruxers are not aware of their bruxism and only 5-10% go on to develop symptoms such as jaw pain and headache. Teeth hollowed by previous decay (caries), or dental drilling, may collapse, as the cyclic pressure exerted by bruxism is extremely taxing on the tooth structure.

Diagnoses

Bruxism is not the only cause of tooth wear. Over-vigorous brushing, abrasives in toothpaste, acidic soft drinks and abrasive foods can also be contributing factors; each has characteristic wear patterns that a trained professional can identify.

The effects of bruxing may be quite advanced before sufferers are aware they brux. Abraded teeth are usually brought to the patient's attention during a routine dental examination. If enough enamel has been abraded, the softer dentine will be exposed and abrasion will accelerate. This opens the possibility of dental decay and tooth fracture, and in some people, gum recession. Early intervention by a dentist is advisable.

A recently introduced device called the BiteStrip enables at-home overnight testing for sleep bruxism. It is proposed that this might help diagnose bruxism before damage appears on the teeth. The device is a miniature electromyograph machine that senses jaw muscle activity while the patient sleeps. A dentist can establish the frequency of bruxing, which helps in formulating a treatment plan. Anyone having major occlusal rehabilitation should be aware that bruxism can easily ruin prosthetic dental work.

Treatment

There is no accepted cure for bruxism.

Mouthguards and Repositioning Splints

Ongoing management of bruxism is based on minimizing the abrasion of tooth surfaces by the wearing of an acrylic dental guard or splint, designed to the shape of an individual's upper or lower teeth from a bite mould. Mouthguards are obtained through visits to a dentist for measuring, fitting, and ongoing supervision. There are four possible goals of this treatment: (1) to constrain the bruxing pattern such that serious damage to the temperomandibular joints is prevented; (2) to stabilize the occlusion by minimizing the gradual changes to the positions of the teeth that typically occur with bruxism; (3) to prevent tooth damage; and (4) to enable a bruxism practitioner to judge — in broad terms — the extent and patterns of bruxism, through examination of the physical indentations on the surface of the splint. A dental guard is typically worn on a long-term basis during every night's sleep.

Professional treatment is medically recommended to ensure proper fit, make ongoing adjustments as needed, and check that the occlusion (bite) has remained stable. Monitoring of the mouthguard is suggested at each dental visit.

Another type of device sometimes given to a bruxer is a repositioning splint. A repositioning splint may look similar to a traditional night guard, but is designed to change the occlusion, or "bite," of the patient. Randomly controlled trials with these type devices generally show no benefit over more conservative therapies and they should be avoided under most if not all circumstances.

The NTI-tss device is another option that can be considered. The NTI covers only the front teeth and prevents the rear molars from coming into contact, thus limiting the contraction of the temporalis muscle. The NTI must be fit by your dentist.

The efficacy of such devices is debated. Some writers propose that irreversible complications can result from the long-term use of mouthguards and repositioning splints.

Vitamin Supplements

There is limited evidence that suggests taking certain combinations of vitamin supplements may alleviate bruxism.

Biofeedback

Various biofeedback devices are curently available, but their effectiveness is as yet unproven. While anecdotal evidence suggests that they may be useful, some bruxism authorities remain unconvinced.

One biofeedback mechanism that has significant promise was developed by Moti Nissani, PhD and is called "The Taste-Based Approach to the Prevention of Teeth Clenching and Grinding." The therapy involves suspending sealed packets containing a bad-tasting substance (e.g. hot sauce, vinegar, denatonium benzoate, etc.) between the rear molars using an orthodontic-style appliance. Any attempt to bring the teeth together will rupture the packets and alert the user to the habit. While no cure exists for bruxism, this approach, if implemented properly and rigorously, has promise to be an infinitely effective treatment for bruxism. Importantly, the Taste-Based Approach does not suffer from the risk of desensitization that other available sound-based biofeedback approaches may have. (There is effectively no limit to the aversive taste of certain substances. We can therefore be sure that some harmless substance exists that will alert anyone to the habit.)

One of these devices, the Oralsensor, comprises a pneumatic pouch embedded in a soft polymer plate that fits over upper or lower teeth. When the teeth come together—to a threshold pressure set each night by the user—an alarm is sounded in an earpiece worn by the user. Another biofeedback device, GrindAlert, is a battery-powered device that sounds a tone when it senses EMG (electromyographic) muscle activity in the temporalis muscles of the forehead. This device delivers nightly data on (1) the number of bruxism events that last for at least two seconds, and (2) the total duration of those events. The volume of the alarm and the sensitivity of the piezo device to EMG signals from the muscles are adjustable.

In 2005, a new type of occlusive device was patented that produces a movement incompatible with teeth clenching. When nighttime bruxism occurs, people breathe through the nose. The device forces people to breathe through the mouth; by forcing the opening of the mouth, the device is claimed to stop clenching. The occlusive device has an electromyogram system that monitors the electric activity of the jaw muscle via wireless electrodes. These electrodes transfer jaw-muscle activity by radio frequency to an external monitoring system. Once the signal has been interpreted by the monitoring system, if a patient clenches (i.e., if the signal transmitted by the electrodes is higher than a given threshold), the monitoring unit sends a radio frequency signal to a transceiver integrated in a mechanical actuator. The mechanical actuator has two occlusive flaps that block the nostrils, forcing breathing to occur through the mouth. Once the patient stops clenching (i.e., once the signal is under the threshold), the flaps open, allowing breathing through the nose again. The occlusive device does not wake up people since it blocks nostrils slowly, and it never closes them completely to avoid sleep disruption.

Meditation and Relaxation Techniques

Sufferers may find that meditation and relaxation techniques may help to reduce teeth grinding.

Repairing Damage to Teeth from Bruxism

Damaged teeth can be repaired by replacing the worn natural crown of the tooth with prosthetic crowns. Materials used to make crowns vary; some are less prone to breaking than others, and can last longer. Porcelain fused to metal crowns may be used in the anterior (front) of the mouth; in the posterior, full gold crowns are preferred. All porcelain crowns are now becoming more and more common and work well for both anterior and posterior restorations. To protect the new crowns and dental implants, an occlusal guard should be fabricated to wear during sleep.


(adapted from Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/bruxism)





Findings From Current Research

Botulinum Toxin in the Treatment of Tremors, Dystonias, Sialorrhea and Other Symptoms Associated with Parkinson's Disease

Authors: Sheffield JK, Jankovic J.

Department of Neurology, Baylor College of Medicine, Parkinson's Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. jksheffi@bcm.edu

Botulinum toxins are an effective treatment modality for a growing number of neurologic conditions. Although there has been varied interest and success in their use, they have been studied for a variety of conditions associated with Parkinson's disease. Conditions reviewed in this paper include hand and jaw tremor, dystonia, blepharospasm and apraxia of eyelid opening, bruxism, camptocormia, freezing of gait, sialorrhea and constipation. We will make comments when applicable on our unique experience with botulinum toxin in these conditions. Other conditions associated with Parkinson's disease, which will not be reviewed here, but may benefit from botulinum toxin treatment include anterocollis (also known as dropped head syndrome), hyperhidrosis, seborrhea and overactive bladder.

Journal: Expert Rev Neurother. 2007 Jun;7(6):637-47.
Adapted from PubMed; click here to access full journal article.




Bruxism in Children: Effect on Sleep Architecture and Daytime Cognitive Performance and Behavior

Authors: Herrera M, Valencia I, Grant M, Metroka D, Chialastri A, Kothare SV.

Department of Dental Medicine, St. Christopher's Hospital for Children, Drexel University College of Medicine, Philadelphia, PA [corrected] USA. marceher@dental.upenn.edu

STUDY OBJECTIVES: Sleep bruxism is an involuntary mandibular movement with tooth grinding during sleep. The prevalence of sleep bruxism in children is high and may lead to frequent arousals with altered daytime functioning. We investigated the sleep architecture, the incidence of gastroesophageal reflux, and the daytime cognitive behavioral functioning in a group of children with sleep bruxism. DESIGN-PATIENTS: This prospective pilot study included 10 children. Polysomnographic data with pH-probe analysis was compared with 10 age- and sex-matched controls. Each patient completed a dental evaluation, a nighttime polysomnogram, and cognitive behavioral tests (Kaufman Brief Intelligence Test and Achenbach Child Behavior Checklist). RESULTS: Eight of 10 children had clinically significant bruxism and the 2 remaining patients had recent teeth exfoliation. There was no difference on sleep architecture between patients and controls, except for a higher arousal index for the bruxism group (36.7 vs 20.7, p < .007). Sleep bruxism occurred more frequently in stage 2 and rapid eye movement sleep, with arousals in 66% of the cases. There was no relationship of bruxism to gastroesophageal reflux or intelligence. However, 40% of the patients had elevated scores on the Achenbach Child Behavior Checklist, indicating significant attention and behavior problems, and there were moderate correlations between the arousal index and several of the behavior-problem scales from the Achenbach Child Behavior Checklist (0.5 to 0.6). CONCLUSIONS: The data suggest that children with bruxism have a higher arousal index, which may be associated with an increased incidence of attention-behavior problems. Future studies investigating pediatric sleep bruxism will need to focus on behavior issues that may be prevalent in this population.

Journal: Sleep. 2006 Sep 1;29(9):1143-8.
Adapted from PubMed; click here to access full journal article.




The Use of Botulinum Toxin-A in the Treatment of Severe Bruxism in a Patient with Autism: A Case Report

Authors: Monroy PG, da Fonseca MA.

pmonroy@smilemichigan.com

This case report describes an alternative method for reducing bruxism in a special needs patient who was not a candidate for an intraoral appliance. Bruxism is often seen in patients with special needs and can result in excessive dental wear, temporo-mandibular joint pain, avulsion of teeth and other problems. Current methods of management are not typically effective in this population because most require patient compliance. An 11-year-old male diagnosed with autism and Bannayan-Zonana syndrome received bilateral injections of botulinum toxin type-A (Botox Allergan Pharmaceuticals, Irvine CA) in the masseter muscle. The patient's condition was followed up via post-operative telephone interviews with the parents for 60 days. A reduction in the frequency and severity of bruxism was reported. The only side effects noted were soreness at the injection site and mild, temporary drooling. Although further research is required to determine the optimal doses and injection frequency, botulinum toxin type-A appears to be an alternative method for controlling bruxism in the special needs population.

Journal: Spec Care Dentist. 2006 Jan-Feb;26(1):37-9.
Adapted from PubMed; click here to access full journal article.




Prevalence of Bruxism and Associated Correlates in Children as Reported by Parents

Authors: Cheifetz AT, Osganian SK, Allred EN, Needleman HL.

Children 's Hospital Boston, MA, USA. cheifetz@alumni.brown.edu

PURPOSE: The purpose of this study was to determine the prevalence of childhood bruxism and associated correlates, as reported by parents. METHODS: A cross-sectional survey of parents was conducted at 4 private pediatric dental offices and the Children's Hospital Boston Dental Clinic. Data were gathered via a self-administered questionnaire offered to the parents of children under age 17. Factors were evaluated for association with bruxism using chi-square tests and multivariate logistic regression. RESULTS: Based on 854 surveys analyzed, the children's mean age was 8.1 years and 52% were female. Caucasians represented 87% of the population, and 90% of the parents had attained a high school diploma. The overall prevalence of reported bruxism was 38%. Five percent of the parents reported that their children had subjective symptoms of temporomandibular disorder (TMD); however, these were not associated with reported bruxism. A child with a psychological disorder had a 3.6 times greater likelihood of bruxism. If either parent had a history of bruxism, their child was 1.8 times more likely to brux. If bedroom doors were open, parents reported bruxism 1.7 times more often. Children who drooled at night were 1.7 times more likely to brux, while sleeptalking children were 1.6 times more likely to brux. CONCLUSIONS: (1) Of the 38% of parents reporting that their children brux, familial history, open bedroom doors, drooling, sleeptalking, and psychological disorders were significantly associated with the reported bruxism. (2) While 5% of parents reported that their children had at least one TMD symptom, no TMD symptoms were associated with reported bruxism.

Journal: J Dent Child (Chic). 2005 May-Aug;72(2):67-73.
Adapted from PubMed; click here to access full journal article.




Tiagabine May Reduce Bruxism and Associated Temporomandibular Joint Pain

Authors: Kast RE.

Department of Psychiatry, University of Vermont, Burlington 05401, USA. rekast@email.com

Tiagabine is an anticonvulsant gamma-aminobutyric acid reuptake inhibitor commonly used as an add-on treatment of refractory partial seizures in persons over 12 years old. Four of the 5 cases reported here indicate that tiagabine might also be remarkably effective in suppressing nocturnal bruxism, trismus, and consequent morning pain in the teeth, masticatory musculature, jaw, and temporomandibular joint areas. Tiagabine has a benign adverse-effect profile, is easily tolerated, and retains effectiveness over time. Bed partners of these patients report that grinding noises have stopped; therefore, the tiagabine effect is probably not simply antinociceptive. The doses used to suppress nocturnal bruxism at bedtime (4-8 mg) are lower than those used to treat seizures.

Journal: Anesth Prog. 2005 Fall;52(3):102-4.
Adapted from PubMed; click here to access full journal article.




Join Now - Become a free member and get notified about studies in your area when they become available.

Browse Our Current Studies - Look over all of our current studies being conducted throughout the United States.

View Information and Clinical Trials for Other Conditions - Access all of our health-related content.
Depression - NATIONWIDE
in NATIONWIDE,


Asthma in African Americans - NATIONWIDE
in NATIONWIDE,


Diabetes (Insulin Delivery) - NATIONWIDE
in NATIONWIDE,


Genital Warts - NATIONWIDE
in NATIONWIDE,


Atrial Fibrillation (Lovaza) - NATIONWIDE
in NATIONWIDE,


ADHD in Children and Adolescents - NATIONWIDE
in NATIONWIDE,


B-Cell Lymphoma - NATIONWIDE
in NATIONWIDE,


Treatment Resistant Depression - NATIONWIDE
in NATIONWIDE,


Brain Tumors and Brain Cancers - NATIONWIDE
in NATIONWIDE,


 


© 1998-2008 Clinical Trials Home | Links | Terms And Conditions | Sitemap | Suggestion/Feedback
All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.